← Back to headlines
Parabilis Medicines Sets Biotech IPO Record with $670 Million Offering
Parabilis Medicines has set a new record in the biotech sector by raising $670 million in its initial public offering. The company priced its upsized IPO at $19 or $20 per share, marking a significant achievement in the industry.
10 Jun, 06:52 — 10 Jun, 06:52
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: seeking-alpha · 10 Jun, 06:52|Full coverage: 2 · 9h|Window: 9h
Left-leaningCenterRight-leaning
